Kavain vs Semax
Side-by-side comparison of Kavain and Semax: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Kavain
Semax
Kavain
Kavain (kawain) is the principal kavalactone in kava (Piper methysticum) and the main compound behind kava's calming, anxiolytic effect. It positively modulates GABA-A receptors outside the benzodiazepine site and…
No vendor price on file.
Full Kavain profileSemax
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro, MEHFPGP, 813 Da molecular weight) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the 1980s. The compound is derived…
Lowest listed price: $32.90 across 5 listings
Full Semax profileSide-by-side comparison
| Attribute | Kavain | Semax |
|---|---|---|
| Category | Nootropics | Nootropics |
| Research Stage | Preclinical for isolated kavain (in-vitro and animal mechanistic data). Human randomized controlled trials exist for the parent standardized kava extract, of which kavain is the principal kavalactone; the single molecule itself has not been trialed alone. | Approved in Russia; registered as a prescription intranasal solution |
| Mechanism of Action | Kavain is the most abundant kavalactone in kava (Piper methysticum) and the main driver of the plant's calming activity. It is a research-use-only compound; the mechanisms below come from in-vitro and animal work on isolated kavain plus human trials of the… | Primary Mechanism: Multi-Pathway Neurotrophic Activation Semax produces its effects through coordinated activation of multiple neurotrophic, neurotransmitter, and neuroprotective pathways. Unlike conventional nootropics that target a single system (modafinil… |
| Half-Life | Not firmly established for isolated kavain in humans. Kavalactones are lipophilic and rapidly absorbed, with subjective effects generally lasting a few hours. Limited pharmacokinetic data preclude a precise elimination half-life. | ~2-3 minutes plasma half-life (functional neurological effects persist 12-24 hours due to BDNF/NGF gene expression changes) |
| Typical Dose Range | 50-250 mg | 100-900 mcg intranasal daily (0.1% solution: 2-3 drops per nostril 2-3x daily); 1% solution used for acute stroke in Russian clinical protocols |
| Dosing Frequency | 1-2 times daily, as needed; not intended for continuous long-term daily use | Intranasal 1–3 times daily |
| Administration | — | Intranasal |
| Side Effects | Commonly mild: GI upset/nausea, headache (more headaches were reported in the kava arm than placebo in a GAD trial [PMID:23635869]), daytime drowsiness, and mild dizziness. With chronic heavy use: 'kava dermopathy', a reversible dry, scaly, yellowed skin rash.… | Overall Safety Profile Semax has an excellent safety profile across 20+ years of Russian clinical use. In acute stroke trials, cognitive studies, and pediatric applications, Semax has demonstrated consistent tolerability with minimal adverse event burden. This… |
| Molecular Weight | 230.26 g/mol (C14H14O3; PubChem CID 837). Naturally occurring form is the (+)-enantiomer. | 813.9 Da |
| Common Vial Sizes | — | 5mg, 10mg |
Price History
5 data points- OF
- Half Nattys
- Ion Peptide
- BHG Labs
Kavain: potential benefits
- Reduced anxiety and nervous tension - the parent standardized kava extract (of which kavain is the principal kavalactone) produced a moderate anxiolytic effect versus placebo in generalized anxiety disorder RCTs [PMID:23635869][PMID:19430766]
- Physical and mental relaxation without the heavy sedation or dependence profile of benzodiazepines, since kavain modulates GABA-A outside the benzodiazepine site [PMID:27332705]
- Calming and sleep-onset support, reported anecdotally with evening kava/kavain use (isolated-kavain benefit is extrapolated from extract data plus community use, not directly trialed)
- Mild muscle relaxation and a soothing analgesic feel, consistent with kavain's effects on voltage-gated Na+ and L-type Ca2+ channels [PMID:9690349][PMID:11642654]
- Sociable, clear-headed calm frequently described in traditional and community use of kava beverages
Semax: potential benefits
- Rapid BDNF/TrkB upregulation in the hippocampus, supporting synaptic plasticity and learning (PMID: 16996037)
- Neuroprotective, immunomodulatory gene-expression changes in focal cerebral ischemia (middle cerebral artery occlusion) models (PMID: 28255762)
- Cognitive enhancement including improved attention, working memory, and processing speed
- Dopaminergic modulation that may support motivation and executive function (preclinical data)
- Stroke recovery facilitation - accelerated functional recovery and improved Barthel Index in ischemic stroke patients; approved in Russia for ischemic stroke (PMID: 29798983)
- Anxiolytic and anti-asthenic effects reported in Russian clinical use, attributed to neurotrophic and monoaminergic modulation
- Non-addictive cognitive support without tolerance development or withdrawal at standard doses
Frequently asked
What's the difference between Kavain and Semax?
Kavain is a nootropics that kavain is the most abundant kavalactone in kava (piper methysticum) and the main driver of the plant's calming activity. it is a research-use-only compound; the mechanisms below…. Semax is a nootropics that primary mechanism: multi-pathway neurotrophic activation semax produces its effects through coordinated activation of multiple neurotrophic, neurotransmitter, and neuroprotective…. The two differ in mechanism, half-life (Not firmly established for isolated kavain in humans. Kavalactones are lipophilic and rapidly absorbed, with subjective effects generally lasting a few hours. Limited pharmacokinetic data preclude a precise elimination half-life. vs ~2-3 minutes plasma half-life (functional neurological effects persist 12-24 hours due to BDNF/NGF gene expression changes)), and typical dose range.
Which has the longer half-life, Kavain or Semax?
Kavain has a half-life of Not firmly established for isolated kavain in humans. Kavalactones are lipophilic and rapidly absorbed, with subjective effects generally lasting a few hours. Limited pharmacokinetic data preclude a precise elimination half-life.. Semax has a half-life of ~2-3 minutes plasma half-life (functional neurological effects persist 12-24 hours due to BDNF/NGF gene expression changes). Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Can you stack Kavain and Semax?
Stacking depends on mechanism overlap, safety profile, and goals. Kavain and Semax should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Kavain or Semax
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. Every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.